(Q44228840)

1 December 2017

Double patch closure of ventricular septal defect with increased pulmonary vascular resistance (English)

1 reference

ventricular septal defect

1 December 2017

1 reference

Novick WM

1

1 reference

1 December 2017

Gurbuz AT

2

1 reference

1 December 2017

Watson DC

3

1 reference

1 December 2017

Lazorishinets VV

4

1 reference

1 December 2017

Perepeka AN

5

1 reference

1 December 2017

Malcic I

6

1 reference

1 December 2017

Marinovic B

7

1 reference

1 December 2017

Alpert BS

8

1 reference

1 December 2017

DiSessa TG

9

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

The Annals of Thoracic Surgery

1 December 2017

1 reference

1 December 2017

66

1 reference

1 December 2017

1533-1538

1 reference

1 December 2017

5

1 reference

Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Natural and modified history of isolated ventricular septal defect: a 17-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Surgical management of complete atrioventricular septal defects. A twenty-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Pulmonary vascular resistance in infants after cardiac surgery: role of carbon dioxide and hydrogen ion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Creation of a one-way interatrial communication in the treatment of critical pulmonary stenosis with intact ventricular septum: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Atrial septal defect for right ventricular failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Unidirectional valve patch for repair of cardiac septal defects with pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Pulmonary vascular resistance during exercise late after repair of large ventricular septal defects. Relation to age at the time of repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Natural and post-operative history of pulmonary vascular obstruction associated with ventricular septal defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Pulmonary arterial changes in patients with ventricular septal defects and severe pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

High-pressure, high-resistance ventricular septal defect. Surgical results of closure through right atrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Verapamil in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2898%2900956-4

10.1016/S0003-4975(98)00956-4

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference